Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-01-01 @ 4:14 PM
Study NCT ID:
NCT00875966
Status:
COMPLETED
Last Update Posted:
2017-03-29
First Post:
2009-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions
Sponsor:
Sandoz
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AA17045
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Eric Mittleberg, Ph.D., VP Product Development
Old Organization:
Sandoz Inc.